GlassScriptPhysician profile
Praneeth Vemulapalli
NPI 1760642037
$11,260.50
in general payments reported to CMS, 2019-2025
58 companies · $2,072 in 2025
The $2,072 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,633 · 2020: $1,363 · 2021: $677 · 2022: $1,442 · 2023: $1,541 · 2024: $1,532 · 2025: $2,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,999 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,998.94 |
| Education | $146.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,086.38 | 2019-2020 | |
| Urogen Pharma, INC. | $853.22 | 2022-2025 | Jelmyto |
| Antares Pharma, INC. | $708.98 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $673.40 | 2019-2025 | Erleada, Akeega, Stelara |
| Angiodynamics, INC. | $593.41 | 2025 | Nanoknife |
| Bayer Healthcare Pharmaceuticals INC. | $477.88 | 2019-2025 | |
| Medtronic, INC. | $455.15 | 2021-2025 | Interstim |
| Sumitomo Pharma America, INC. | $446.51 | 2023-2025 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $425.70 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $382.95 | 2019-2025 | Lupron Depot |
| Astellas Pharma US INC | $378.74 | 2019-2023 | Xtandi, Myrbetriq |
| Medtronic USA, INC. | $273.62 | 2019-2020 | |
| Pfizer INC. | $245.99 | 2019-2025 | |
| Travere Therapeutics, INC. | $200.03 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $188.25 | 2019-2025 | Adstiladrin |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praneeth Vemulapalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.